No Detail Found!

Cluster of Differentiation 5 (CD5) Levels in the Plasma of Children with Autism Spectrum Disorder (ASD).

Author(s)
Dost Muhammad Halepoto Autism Research and Treatment Center, Al-Amodi Autism Research Chair, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia
Abdulrahman Mohammed Alhowikan Department of Physiology, Faculty of Medicine, King Saud University, Riyadh-11461, Saudi Arabia
Laila AL Ayadhi Autism Research and Treatment Center, Al-Amodi Autism Research Chair, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia
Abstract
Objective: To investigate the cluster of differentiation 5 (CD5) plasma levels and their association with childhood autism rating scale (CARS) in subjects with autism spectrum disorder (ASD) compared to age and gender matched healthy controls, and to explore the link between CD5, severity, and autoimmunity in autism. Study Design: Case-control study. Place and Duration of Study: Autism Research and Treatment Center, Al-Amodi Autism Research Chair, Department of Physiology, Faculty of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia, from October 2014 to May 2015. Methodology: CD5 levels were determined in the plasma of thirty-one (31) patients using enzyme-linked immunosorbent assay (ELISA), categorized as mild-moderate and severe as indicated by their Childhood Autism Rating Scale (CARS) score and compared to thirty-three (33) age and gender-matched control samples. Results: The preliminary data indicated that children with severe autism (n=12), exhibited significantly (p=0.02) higher plasma level of CD5 [0.55 (0.14-12) pg/ml {median (interquartile range=IQR)}] than those of normal controls [n=33, 0.29 (0.08-0.79) pg/ml {median (IQR)}] and children with mild to moderate autism [n=19, 0.26 (0.13-1.42) pg/ml, {median (IQR)}, p=0.08]. However, there was no significant difference between the CD5 levels of children with mild to moderate autism and normal controls (p = 0.62). Diagnoses of autistic children based on the CARS score >30. Disease severity and the CARS score, which represent stereotyped patterns of behavior in children with autism, were positively correlated (r = 0.43, p = 0.02). Conclusion: The high CD5 plasma levels in patients with severe ASD, probably indicated that CD5 might be implicated in the physiology of autism. However, this finding should be treated with caution until further investigations are performed with larger populations to determine whether the increase in plasma CD5 levels is a mere consequence of autism or it plays a pathogenic role in the disease.
Publication Details
Page(s) 149-152
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 27, Issue: 3, Year: 2017

Request the full text from PASTIC

Keywords
Autism spectrum disorder (ASD). Childhood autism rating scale (CARS). Cluster of differentiation 5 (CD5).
References
2000.Diagnostic and statistical manual of mental disorders (4th edn, Text Revision), -
ElaminNE,Al-AyadhiLY, 2014.Brain autoantibodies in autism spectrum disorder,Biomarks Med 8 345 -52
KippsTJ, 1989.The CD5 B cell,Adv Immunol 47 117 -85
TarakhovskyA,KannerSB,HombachJ,LedbetterJA,MüllerW,KilleenN, 1995.A role for CD5 in TCR-mediated signal transduction and thymocyte selection,Science 269 535 -7
SigalLH, 2012.Basic science for the clinician 54: CD5,J Clin Rheumatol 18 83 -8
GanguliR,RabinBS, 1993.CD5 positive B-lymphocytes in schizophrenia: No alteration in numbers or percentage as compared with control subjects,Psychiatry Res 48 69 -78
OnoreC,CareagaM,AshwoodP., 2012.The role of immune dysfunction in the pathophysiology of autism,Brain Behav Immun 26 383 -92
EngstromHA,OhlsonS,StubbsEG,MaciulisA,CaldwellV,OdellJD, 2003.Decreased expression of CD95 (FAS/APO-1) on CD4+ T-lymphocytes from participants with autism,J Dev Phys Disabil 15 155 -63
ConnollyAM,ChezMG,PestronkA,ArnoldST,MehtaS,DeuelRK, 1999.Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders,J Pediatr 134 607 -13
WarrenRP,OdellJD,WarrenWL,BurgerRA,MaciulisA,DanielsWW, 1997.Brief report: Immunoglobulin a deficiency in a subset of autistic participants,J Autism Dev Disor 27 187 -92
GuptaS., 2000.Immunological treatments for autism,J Autism Dev 30 475 -9
CohlyHH,PanjaA, 2005.Immunological findings in autism,Int Rev Neurobiol 71 317 -41
EnstromAM,Van de WaterJA,AshwoodP., 2009.Autoimmunity in autism,Curr Opin Investig Drugs 10 463 -73
VanchuA, 2000.Antinuclear antibodies: Clinical applications,J Postgrad Med 46 144 -8
MostafaGA,El-SherifDF,Al-AyadhiLY, 2014.Systemic auto-antibodies in children with autism,J Neuroimmunol 272 94 -8
CohlyHH,PanjaA, 2005.Immunological findings in autism,Int Rev Neurobiol 71 317 -41
0

Citations

0

Downloads

63

Views